6137 POSTER Biological Analysis of Phase II Study Evaluating the Activity of Cetuximab Combined to Oxaliplatin and Fluoropirimidine (TEGAFOX-E) as First Line Treatment in Metastatic Colorectal Cancer (mCRC) Pts by the Italian Trials in Medical Oncology (I.T.M.O.) Group

Authors :: A. Martinetti
Emilio Bajetta
Claudia Bertan
F. Perrone
Roberto Buzzoni
Katia Fiorella Dotti
M. Pi Bartolomeo
Andrea Lampis
S. Pilotti
Filippo Pietrantonio
Source :: European Journal of Cancer. 47:S433
Publication Year :: 2011
Publisher :: Elsevier BV, 2011.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Cetuximab
Colorectal cancer
business.industry
Phases of clinical research
medicine.disease
Oxaliplatin
First line treatment
Internal medicine
medicine
business
medicine.drug

Full Text Access

Tools